Omnes Capital's investments

Sector 
Medical devices
Entry Date 
2013
Business 
Venture Capital

TISSIUM

Life science company developing fully synthetic, biomorphic programmable polymers

TISSIUM is a privately-owned life sciences company based in Paris, France that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs.The company’s platform is based on a proprietary polymer family with unique properties including the ability to conform to, and integrate with, surrounding tissue to enable natural healing. Furthermore, the modular design of the polymers enables customization to match tissue-specific requirements for different therapeutic areas. The company also develops delivery and activation devices for enhanced performance and usability of its family of polymers.The Company’s technology is based on world-class research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women’s Hospital), who co-founded the company in 2013.

Latest news
Sector 
Industry
Entry Date 
2019
Business 
Venture Capital

Solvionic

Fine chemistry (ionic liquids)

Founded in 2003 and based in Toulouse, Solvionic uses innovative technology to produce high purity materials (ionic liquids), used in batteries of the future; safer, more powerful and longer lasting. The company produces ionic liquids with numerous applications in the fields of catalysis and surface treatment, but also in energy storage. The latter has been a priority target since 2013, driven by a rapidly growing battery and supercapacitor market. Its products, used as electrolytes, not only guarantee the safety of energy storage devices, but also significantly enhance their energy performance, cyclability and recyclability.

Latest news
Sector 
Medical devices
Entry Date 
2019
Business 
Venture Capital

www.newronika.com

Newronika is the first company to develop a closed-loop system for the treatment of Parkinson’s disease

Newronika is the spin-off company of two of the world-leading research institutions in the field of Neurology, the Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika restores brain and body functions with its innovative technology, translating their deep knowledge on bio-signal decoding into clinical practice with the aim of developing new treatments and improve existing ones. Newronika comprises a multidisciplinary team involving neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Latest news
Entry Date 
2019
Business 
Venture Capital

Wizaplace

SaaS solution publisher for building all-in-one marketplaces

Founded in 2012, Wizaplace has developed an all-in-one marketplace creating platform. The Saas solution brings in one unique environment all the functionalities needed to create marketplaces for B2B and B2C products or services. It natively integrates the back-office administrator to operate the platform on a daily basis, back-office sellers to aggregate third party catalogue, and the front office, the marketplace’s front display. Wizaplace offers a robust and complete solution, delivered on a turnkey basis, making it possible to accelerate the deployment of marketplaces for project developers. Among its customers, the company has start-ups, SMEs and large groups (Macif, Engie, Somfy, Arkea, FFF, Cash Converters, Atalian). Located in Lyon, Wizaplace also has offices in Paris 16.

Latest news
Sector 
Web
Entry Date 
2017
Business 
Venture Capital

Bizay

Online selling platform both physical and digital marketing products

Founded in 2013 (Lisbon), 360imprimir, renamed Bizay in 2019, offers on its online selling platform both physical and digital marketing products with a high level of customization. The startup differentiates itself with a strong outsourcing culture - from the production to the customer service - that allows a great scalability of its model. Indeed, Bizay has already a presence in Portugal, Spain, Brazil and Mexico. The fabless company primarily targets micro-businesses, i.e. businesses with less than 10 employees.

Latest news
Sector 
Pharma
Entry Date 
2019
Business 
Venture Capital

NH TherAguix

Nanomedicine for cancer radiotherapy
Founded in December 2015, and backed by Pulsalys, the technology transfer acceleration company from Lyon Saint-Etienne, NH TherAguix originates a nanomedicine innovation, the AGuIX drug candidate. This product, thanks to its nanometric structure, allows an IV administration and combines three essential attributes to fight tumours: targeting, imaging and treatment. The AGuIX technology is therefore part of the theranostics concept, which relates to a combination of therapy (radiosensitizing effect) and diagnostics (MRI imaging), and more widely in the personalized medicine of tomorrow.
Latest news
Sector 
Pharma
Entry Date 
2019
Business 
Venture Capital

AgomAb Therapeutics

A biotherapeutics company developing agonistic antibodies for regeneration of damaged tissues

AgomAb was founded through a collaboration between argenx and the University of Torino, Italy, based on the groundbreaking work of Paolo Michieli and his translational medicine team. The Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues and has produced a comprehensive preclinical package illustrating different applications in the fields of fibrotic, inflammatory, autoimmune and degenerative diseases. Based in Ghent Belgium, it is backed by an International syndicate of experienced life sciences venture capital investors.

Latest news
Sector 
Medical devices
Entry Date 
2019
Business 
Venture Capital

Therapixel

Artificial intelligence applied to radiology
Created in 2013 by two former INRIA researchers, Therapixel is a world leader in artificial intelligence applied to radiology. Winner of the DREAM Digital Mammography Challenge in 2017, Therapixel is developing an AI-based service for assisting radiologists review screening mammography for breast cancer.
Latest news
Sector 
Web
Entry Date 
2019
Business 
Venture Capital

Teach on Mars

Europe’s leading mobile-native learning technology provider

Teach on Mars is a 100% mobile-native learning technology provider. Our solution helps today’s organisations connect people with the learning and the communities they need to do their jobs and live their lives better. Winner of numerous industry awards, Teach on Mars is recognised as European leader in the mobile learning space. Since its foundation in 2013, the company has delivered its solution to over 130 blue-chip clients, in 20+ languages across more than 90 countries throughout the globe, and today it has bases in Sophia-Antipolis, Paris, Milan, London, Brussels and Casablanca. 80 Teach on Mars staff and an extensive worldwide network of 50 content and technology partners collaborate to equip organisations with the toolset, mindset and skillset required to create their next-generation learning ecosystem. And because Teach on Mars takes its responsibility for the future of our planet seriously, it invests 1% of its revenues in education projects contributing directly to the United Nations Sustainsable Development Goals.

Latest news
Sector 
Web
Entry Date 
2018
Business 
Venture Capital

GEEV

The first app for donating items between individuals

Thanks to a simple and fun service, "Geevers" can easily give and receive items for free in the proximity of their own homes. Available in Paris, Lyon, Marseille, Lille, Bordeaux, Nantes and Toulouse, GEEV has become an obvious alternative to selling, unnecessary storage and the proliferation of waste in the public space.

Latest news

Pages

NewsRoom
Press release
24 March 2020
Covid-19: Cogepart, leader in home food delivery, mobilizes its forces to help the most vulnerable
Covid-19: Cogepart, leader in home food delivery, mobilizes its forces to help the most vulnerable
La Fondation Omnes supports e-Enfance
Publication
Scope, the Omnes review, December 2019
Press release
23 January 2020
Omnes acquires a minority stake in Better Energy, leading Danish solar energy provider and a renewable energy pioneer in Northern Europe, and announces the first closing of its Capenergie 4 fund, at €380 million.
Omnes acquires a minority stake in Better Energy, leading Danish solar energy provider and a renewable energy pioneer in Northern Europe, and announces the first closing of its Capenergie 4 fund, at €380 million.
Job offer
Discover our job offers on Linkedin
5 years 3 weeks ago
Captain Tortue supported since 2018 : interview with Philippe Jacquelinet and Nathalie Coppola
Press release
17 January 2020
Omnes completes primary LBO of Opportunity, a Cloud platform specializing in automated customer interaction management, and signs its fourth deal of its 3rd vintage fund
Omnes completes primary LBO of Opportunity, a Cloud platform specializing in automated customer interaction management, and signs its fourth deal of its 3rd vintage fund

Pages